ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

GlobeNewswireNov 26 20:30

ProKidney (NASDAQ:PROK) Is In A Good Position To Deliver On Growth Plans

Simply Wall StNov 21 19:08

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Futu NewsNov 13 18:38 · Ratings

ProKidney's Progress in FDA Approval and Financial Health

TipRanksNov 13 12:47

ProKidney | 10-Q: Q3 2024 Earnings Report

SECNov 13 05:08 · Announcements

ProKidney GAAP EPS of -$0.14

Seeking AlphaNov 12 23:10